|
?:authorAffiliation
|
-
[\'Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada.\', \'Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada; Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.\', \'Alberta Public Health Laboratory, Alberta Precision Laboratory, Calgary, AB, Canada.\', \'Alberta Public Health Laboratory, Alberta Precision Laboratory, Calgary, AB, Canada; Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada.\', \'Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada; Department Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada.\', \'Faculty of Veterinary Medicine, University of Calgary, Calgary, AB, Canada.\', \'Illucidx Inc., Calgary, AB, Canada.\', \'Department Pathology and Laboratory Medicine, University of California, San Francisco, USA.\', \'Department of Laboratory Medicine, University of Washington, Seattle, WA, USA.\', \'Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.\', \'Department of Microbiology, Immunology, and Infectious Diseases, University of Calgary, AB, Canada; Clinical Section of Microbiology, Alberta Precision Laboratories, Calgary, AB, Canada; Department Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada; Department of Medicine, University of Calgary, Calgary, AB, Canada. Electronic address: drpillai@ucalgary.ca.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}